Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1‐Wnt3a‐β‐Catenin Signaling Axis
Journal of the American Heart Association · 16.05.2023 · 12 (10)
DOI: 10.1161/jaha.122.028866 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 16.05.2023. Verfasst von Luyang Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology The First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu China. Hauptthemen laut MEDLINE: Ventricular Remodeling, Myocardial Infarction. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Myocardial infarction (MI) is a cardiovascular disease with high morbidity and mortality. PI16 (peptidase inhibitor 16), as a secreted protein, is highly expressed in heart diseases such as heart failure. However, the functional role of PI16 in MI is unknown. This study aimed to investigate the role of PI16 after MI and its underlying mechanisms. Methods and Results PI16 levels after MI were measured by enzyme‐linked immunosorbent assay and immunofluorescence staining, which showed that PI16 was upregulated in the plasma of patients with acute MI and in the infarct zone of murine hearts. PI16 gain‐ and loss‐of‐function experiments were used to investigate the potential role of PI16 after MI. In vitro, PI16 overexpression inhibited oxygen–glucose deprivation–induced apoptosis in neonatal rat cardiomyocytes, whereas knockdown of PI16 exacerbated neonatal rat cardiomyocyte apoptosis. In vivo, left anterior descending coronary artery ligation was performed on PI16 transgenic mice, PI16 knockout mice, and their littermates. PI16 transgenic mice showed decreased cardiomyocyte apoptosis at 24 hours after MI and improved left ventricular remodeling at 28 days after MI. Conversely, PI16 knockout mice showed aggravated infract size and remodeling. Mechanistically, PI16 downregulated Wnt3a (wingless‐type MMTV integration site family, member 3a)/β‐catenin pathways, and the antiapoptotic role of PI16 was reversed by recombinant Wnt3a in oxygen–glucose deprivation–induced neonatal rat cardiomyocytes. PI16 also inhibited HDAC1 (class I histone deacetylase) expression, and overexpression HDAC1 abolished the inhibition of apoptosis and Wnt signaling of PI16.
Conclusions
In summary, PI16 protects against cardiomyocyte apoptosis and left ventricular remodeling after MI through the HDAC1‐Wnt3a‐β‐catenin axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology The First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu China.
- School of Medicine Southeast University Nanjing Jiangsu China.
- Cardiovascular Research Center The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University Suzhou China.
ORCID-Profile: Zhenyang Su, Huanyu Shu, Wei Sun
Zitieren
APA
Wang, L., Du, A., Lu, Y., Zhao, Y., Qiu, M., Su, Z., Shu, H., Shen, H., Sun, W., & Kong, X. (2023). Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1‐Wnt3a‐β‐Catenin Signaling Axis. Journal of the American Heart Association, 12(10). https://doi.org/10.1161/jaha.122.028866
Vancouver
Wang L, Du A, Lu Y, Zhao Y, Qiu M, Su Z, et al. Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1‐Wnt3a‐β‐Catenin Signaling Axis. Journal of the American Heart Association. 2023;12(10). doi:10.1161/jaha.122.028866
BibTeX
@article{Wang2023,
author = {Wang, Luyang and Du, Anning and Lu, Yan and Zhao, Yunxi and Qiu, Ming and Su, Zhenyang and Shu, Huanyu and Shen, Hui and Sun, Wei and Kong, Xiangqing},
title = {Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1‐Wnt3a‐β‐Catenin Signaling Axis},
journal = {Journal of the American Heart Association},
year = {2023},
volume = {12},
number = {10},
doi = {10.1161/jaha.122.028866}
}
EUVIMED